The Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Share Price Has Gained 26% And Shareholders Are Hoping For MoreHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)The Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Share Price Has Gained 26% And Shareholders Are Hoping For MoreSimply Wall StSimply Wall St.January 9, 2020ReblogShareTweetShareView photosThese days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick the right individual stocks, you could make more than that. To wit, the Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) share price is 26% higher than it was a year ago, much better than the market return of around 18% (not including dividends) in the same period. That's a solid performance by our standards! Note that businesses generally develop over the long term, so the returns over the last year might not reflect a long term trend. View our latest analysis for Fine Foods & Pharmaceuticals N.T.M In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).Fine Foods & Pharmaceuticals N.T.M went from making a loss to reporting a profit, in the last year.When a company has just transitioned to profitability, earnings per share growth is not always the best way to look at the share price action.We doubt the modest 0.8% dividend yield is doing much to support the share price. Revenue was pretty stable on last year, so deeper research might be needed to explain the share price rise.The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).BIT:FF Income Statement, January 9th 2020MoreWe know that Fine Foods & Pharmaceuticals N.T.M has improved its bottom line lately, but what does the future have in store? This free report showing analyst forecasts should help you form a view on Fine Foods & Pharmaceuticals N.T.MA Different PerspectiveFine Foods & Pharmaceuticals N.T.M boasts a total shareholder return of 27% for the last year (that includes the dividends) . A substantial portion of that gain has come in the last three months, with the stock up 12% in that time. This suggests the company is continuing to win over new investors. Before deciding if you like the current share price, check how Fine Foods & Pharmaceuticals N.T.M scores on these 3 valuation metrics.But note: Fine Foods & Pharmaceuticals N.T.M may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on IT exchanges.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextWhy BE Group AB (publ) (STO:BEGR) Is A Dividend RockstarSimply Wall St.Should You Buy Antevenio, S.A. (EPA:ALANT) For Its Dividend?Simply Wall St.Here's What Absolent Group AB (publ)'s (STO:ABSO) P/E Is Telling UsSimply Wall St.Delfi Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For Next YearSimply Wall St.Fu Yu Corporation Limited Just Released Its Annual Earnings: Here's What Analysts ThinkSimply Wall St.Biocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoCanada Stock Bourse Says Ready for Friday Open After Early CloseBloomberg'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video